indazoles has been researched along with Experimental Mammary Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aparicio, AM; Bonnefous, C; Darimont, BD; Douglas, KL; Govek, SP; Grillot, KL; Hager, JH; Joseph, JD; Julien, JD; Kahraman, M; Kaufman, JA; Lai, AG; Lee, KJ; Lu, N; Moon, MJ; Nagasawa, JY; Prudente, RY; Rix, PJ; Sensintaffar, J; Smith, ND | 1 |
| Chang, LC; Chou, RH; Hsieh, MT; Huang, LJ; Hung, HY; Kuo, SC; Lee, FY; Lin, HY; Teng, CM; Tsai, MT; Yu, YL | 1 |
| Conrads, TP; Haines, DC; Hilton, MB; Kalen, J; Logsdon, D; Morris, H; Patel, NL; Seaman, S; St Croix, B; Stevens, J; Swing, DA; Veenstra, TD; Xu, L; Zudaire, E | 1 |
| Amler, LC; Belvin, M; Berry, L; Friedman, LS; Guan, J; GuhaThakurta, D; Lackner, MR; O'Brien, C; Prior, WW; Punnoose, EA; Sampath, D; Savage, H; Wallin, JJ | 1 |
| Brennan, KR; Clarke, RB; Gregson, HJ; Harrison, H; Landberg, G; Rogerson, L | 1 |
| De Cesare, M; Pratesi, G; Zunino, F | 1 |
| Beggiolin, G; Di Domenico, R; Fiocchi, L; Gallagher, CE; Giuliani, FC; Hacker, MP; Krapcho, AP; Maresch, ME; Menta, E; Oliva, A; Pezzoni, G; Spinelli, S | 1 |
7 other study(ies) available for indazoles and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograft.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Cinnamates; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Indazoles; Mammary Neoplasms, Experimental; Mice; Molecular Structure; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen | 2019 |
YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; Enhancer of Zeste Homolog 2 Protein; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Mammary Neoplasms, Experimental; Mice; Polycomb Repressive Complex 2; Proto-Oncogene Proteins c-cbl; Structure-Activity Relationship | 2014 |
COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models.
Topics: Angiogenesis Inhibitors; Animals; Axitinib; Carcinogenesis; Cell Line, Tumor; Clone Cells; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Female; Humans; Imidazoles; Indazoles; Liver Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoadjuvant Therapy; Signal Transduction; Survival Analysis; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2014 |
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Female; Gene Expression Profiling; Humans; Indazoles; Mammary Neoplasms, Experimental; Mice; Mutation; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Predictive Value of Tests; Receptor, ErbB-2; Sensitivity and Specificity; Sulfonamides; Xenograft Model Antitumor Assays | 2010 |
Contrasting hypoxic effects on breast cancer stem cell hierarchy is dependent on ER-α status.
Topics: Animals; Blotting, Western; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Estrogen Antagonists; Estrogen Receptor alpha; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Nude; Neoplastic Stem Cells; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Tamoxifen; Transplantation, Heterologous | 2013 |
Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; DNA Damage; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Female; Humans; Indazoles; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1996 |
Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4, 3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles).
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Indazoles; Inhibitory Concentration 50; Isoquinolines; Leukemia P388; Male; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1998 |